Booz Allen Hamilton (NYSE: BAH) unveils five-product Vellox cyber platform at RSAC 2026 with autonomous remediation at its core
IntraBio files first-ever FDA application for an Ataxia-Telangiectasia drug with AQNEURSA sNDA submission
Kodiak Gas Services (NYSE: KGS) closes $24m Permian Basin compression deal with 7-year service contract
Read More 9 minute read Pharma Industry News NATCO Pharma (NSE: NATCOPHARM) launches cheapest semaglutide in India at Rs 1,290 on Day 1 of patent expiry NATCO Pharma launches generic semaglutide in India at INR 1,290 on Day 1 of patent expiry. What it means for GLP-1 markets. Read the full analysis. bySrinathMarch 20, 2026